Our findings shed light on the mechanisms of leukemia-induced bone loss
We present a curated panel of 12 readily-usable, cell lines representing the spectrum of molecular subtypes of IDH-wildtype glioblastoma
Our data demonstrate that CD8+XCR1neg DCs possess a unique pattern of endocytic receptors and a restricted TLR profile that is particularly enriched…
Bevacizumab is well tolerated and appears most effective for rapid tumor control to preserve vision and improve morbidity
This multi-center study provides valuable information on the success rate of establishing patient-derived pre-clinical models of diffuse intrinsic po…
Our results show that TRM cells have a fundamental role in the surveillance of subclinical melanomas in the skin by maintaining cancer-immune equilib…
A first of its kind research program at The Kids Research Institute Australia aims to develop new strategies to better treat Aboriginal and Torres St…
Here we report that CHAF1B is required for normal hematopoiesis while its overexpression promotes leukemia
This chapter summarizes recent advances in diffuse intrinsic pontine glioma and potential novel therapies
We provide evidence that targeting leukemia-induced bone loss is a therapeutic strategy for pre-B ALL